This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72512349
rdf:type
wikibase:Item
schema:description
scientific article published on 01 April 1994 наукова стаття, опублікована у квітні 1994 im April 1994 veröffentlicher wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu espublizáu n'abril de 1994
p:P577
wds:Q72512349-D7706D5B-5E53-4EF0-A088-749D197B4420
wdt:P577
1994-04-01T00:00:00Z
p:P2093
wds:Q72512349-67C597BE-4A97-4905-B840-E7AAF84606C3 wds:Q72512349-016C8A94-D66F-44DD-825A-EDAD77A7831C
wdt:P2093
Henry DH Abels RI
rdfs:label
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies
skos:prefLabel
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies
schema:name
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies
p:P1476
wds:Q72512349-FB7885E5-EE13-4FD8-871D-60A22FEFA9C3
wdt:P1476
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies
p:P304
wds:Q72512349-EFF8C1D1-5F5C-40CC-BA0F-871D54A7F38B
wdt:P304
21-28
p:P31
wds:Q72512349-3D02F7B7-0B38-4121-B0AE-BF38DAF5DD05
wdt:P31
wd:Q13442814
p:P921
wds:Q72512349-B910D246-0282-4B07-A2F5-69527A3660B0
wdt:P921
wd:Q974135
p:P698
wds:Q72512349-009BC0E4-54CF-4517-A03D-6E9D430AACA8
wdtn:P698
n5:8202722
wdt:P698
8202722
p:P1433
wds:Q72512349-AEA052C5-61A1-4539-AB12-715462CEF279
wdt:P1433
wd:Q14330412
p:P433
wds:Q72512349-30EE1D6E-5217-4ADC-9502-20C7C5E2B14A
p:P478
wds:Q72512349-DB8EF133-18E1-4C2B-A2ED-56D0AC64A7C3
wdt:P433
2 Suppl 3
wdt:P478
21